Loading patent…
AssigneeYeda Research and Development Co. Ltd.
InventorsMichal Eisenbach-Schwartz, Irun R. Cohen, Michael Sela, Eti Yoles, Jonathan Kipnis
Estimating the term…
Methods are provided for treating injury to or disease of the central or peripheral nervous system. In one embodiment, treatment is effected by administering activated T cells that recognize an antigen of Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to prevent or inhibit neuronal degeneration within the nervous system. In another embodiment, treatment involves administering Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to prevent or inhibit neuronal degeneration in the nervous system, either the central nervous system or the peripheral nervous system. The activated T cells, which have been activated by the presence of Cop 1 or a Cop 1-related peptide or polypeptide, can be administered alone or in combination with Cop 1 or a Cop 1-related peptide or polypeptide.
A method for reducing secondary neuronal degeneration that follows neuronal damage caused by an injury, disease, disorder or condition in the central or peripheral nervous system of an individual in need thereof, other than multiple sclerosis, comprising:
A method for ameliorating the secondary neurodegenerative effects of an injury, disease, disorder or condition that involves neuronal degeneration of the central or peripheral nervous system of an individual in need thereof, other than multiple sclerosis, comprising:
Dependencies are inferred from the claim text.